Healthcare Enterprise Discussion Board http://www.iii.co.uk/investment/detail?code=cotn:HCEG.L&display=discussion http://www.iii.co.uk/icons/logos/uk_logo.gif http://www.iii.co.uk tag:iii.co.uk,2003:tst.9108498
VALiRx...undervalued and off investors radars? But for how long, Hybridan and other brokers are rating this as a BUY with near term price target of 1.66p

BUY and HOLD shares in Biopharmaceutical company ** VALiRx, sp, 0.55p, a great little company,( fully funded). Posting good results researching cancer cures-treatment- compounds, herpes, prostate cancer, chlamydia, alzheimers...full coverage and news articles:

Hybridan raises target price 3-fold to... 1.66p !
http://www.proactiveinvestors.co.uk/companies/news/37128/ValiRx%20has%20its%20price%20target%20increased%20by%20broker%20Hybridan

proactive news/articles: Everyone a 'positive' update
http://www.proactiveinvestors.co.uk/LON:VAL/ValiRx/

Video-interview-unlimited potential of GeneICE
http://www.proactiveinvestors.co.uk/companies/stocktube/760/satu-vainikka-from-valirx-talks-about-the-unlimited-potential-of-geneice-.html

"With ValiRx's lead therapeutic compound VAL201 now in the final stage of the pre-clinical phase, we see a significant jump in valuation.
"The depth of VAL201 pre-clinical package has received a significant boost from a second indication, and the management has already made significant progress in designing Phase 1 clinical trials.
"We have increased our price target to 1.66 pence based on conservative upfront licensing fee values."
http://www.valirx.com/__data/assets/pdf_file/0003/86466/ValiRx_Plc_-_New_Patent_Filing.pdf

ENDOMETRIOSIS IS EXCESSIVELY DEBILITATING, typically seen during the reproductive years and represents one of the MAJOR CAUSES of female infertility.
It has been predicted that the global endometriosis market will reach $1.3billion by 2017 and endometriosis REMAINS A COMMON HEALTH PROBLEM among women, with an estimated 170 million sufferers globally. This estimate is widely considered to BE AN UNDERESTIMATION of the true situation with respect to this condition! By dickie3times ]]> http://www.iii.co.uk/investment/detail?code=cotn:HCEG.L&display=discussion&id=9108498&action=detail Thu, 29 Dec 2011 13:27:00 GMT dickie3times tag:iii.co.uk,2003:tst.8608672 http://www.iii.co.uk/investment/detail?code=cotn:HCEG.L&display=discussion&id=8608672&action=detail Wed, 03 Aug 2011 16:49:00 GMT geoffmango tag:iii.co.uk,2003:tst.8608190 http://www.iii.co.uk/investment/detail?code=cotn:HCEG.L&display=discussion&id=8608190&action=detail Wed, 03 Aug 2011 15:23:00 GMT D J Harker tag:iii.co.uk,2003:tst.8586177 I do not know the answer. I thought the same. There appears to be crime about the HCEG modus operandi By geoffmango ]]> http://www.iii.co.uk/investment/detail?code=cotn:HCEG.L&display=discussion&id=8586177&action=detail Wed, 27 Jul 2011 17:46:00 GMT geoffmango tag:iii.co.uk,2003:tst.8583312
Does anyone know what happens to the patents and right to Ebiox?
Looking at the Ebiox web site it's prospects look promising.
Unless I missed something this was the gem in HCEG product portfolio.

Thanks

Dave Harker By D J Harker ]]> http://www.iii.co.uk/investment/detail?code=cotn:HCEG.L&display=discussion&id=8583312&action=detail Wed, 27 Jul 2011 09:11:00 GMT D J Harker tag:iii.co.uk,2003:tst.8441184 Boooo By Monet01 ]]> http://www.iii.co.uk/investment/detail?code=cotn:HCEG.L&display=discussion&id=8441184&action=detail Thu, 23 Jun 2011 21:17:00 GMT Monet01 tag:iii.co.uk,2003:tst.8428558 http://www.iii.co.uk/investment/detail?code=cotn:HCEG.L&display=discussion&id=8428558&action=detail Wed, 22 Jun 2011 07:27:00 GMT geoffmango tag:iii.co.uk,2003:tst.8428513 http://www.iii.co.uk/investment/detail?code=cotn:HCEG.L&display=discussion&id=8428513&action=detail Wed, 22 Jun 2011 07:19:00 GMT FORCEMODE tag:iii.co.uk,2003:tst.8428463 http://www.iii.co.uk/investment/detail?code=cotn:HCEG.L&display=discussion&id=8428463&action=detail Wed, 22 Jun 2011 07:09:00 GMT geoffmango tag:iii.co.uk,2003:tst.8366718 http://www.iii.co.uk/investment/detail?code=cotn:HCEG.L&display=discussion&id=8366718&action=detail Wed, 08 Jun 2011 16:30:00 GMT geoffmango tag:iii.co.uk,2003:tst.8364520 http://www.iii.co.uk/investment/detail?code=cotn:HCEG.L&display=discussion&id=8364520&action=detail Wed, 08 Jun 2011 11:26:00 GMT upupandway tag:iii.co.uk,2003:tst.7850894 http://www.iii.co.uk/investment/detail?code=cotn:HCEG.L&display=discussion&id=7850894&action=detail Wed, 23 Feb 2011 08:17:00 GMT geoffmango tag:iii.co.uk,2003:tst.7850891 http://www.iii.co.uk/investment/detail?code=cotn:HCEG.L&display=discussion&id=7850891&action=detail Wed, 23 Feb 2011 08:17:00 GMT geoffmango tag:iii.co.uk,2003:tst.7849175 http://www.iii.co.uk/investment/detail?code=cotn:HCEG.L&display=discussion&id=7849175&action=detail Tue, 22 Feb 2011 19:46:00 GMT college boys tag:iii.co.uk,2003:tst.7846264 http://www.iii.co.uk/investment/detail?code=cotn:HCEG.L&display=discussion&id=7846264&action=detail Tue, 22 Feb 2011 13:14:00 GMT Monet01